Astrana Health (ASTH) Gains from Investment Securities (2015 - 2026)

Astrana Health (ASTH) has 11 years of Gains from Investment Securities data on file, last reported at -$1.2 million in Q1 2026.

• Quarterly Gains from Investment Securities fell 120.18% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.9 million (down 153.14% YoY) and the FY2025 annual result came in at $174824.0, down 55.01% from the prior year.
• Gains from Investment Securities rose to -$1.2 million in Q1 2026 per ASTH's latest filing, from -$7.8 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $5.7 million in Q1 2025, with the low at -$7.8 million in Q4 2025.
• Average Gains from Investment Securities over 5 years is $572552.1, with a median of $233500.0 recorded in 2022.
• The widest YoY moves for Gains from Investment Securities: up 12492.93% in 2025, down 490.37% in 2025.
• Astrana Health's Gains from Investment Securities stood at $138000.0 in 2022, then surged by 135.51% to $325000.0 in 2023, then surged by 513.23% to $2.0 million in 2024, then sank by 490.37% to -$7.8 million in 2025, then jumped by 85.14% to -$1.2 million in 2026.
• Business Quant data shows ASTH's Gains from Investment Securities at -$1.2 million in Q1 2026, -$7.8 million in Q4 2025, and $2.7 million in Q3 2025.